Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Dimou

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Thoracic Cancer|September 20, 2023
Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1 mediated by AXL overexpressionTara L Peters, Nan Chen, Logan C Tyler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2026
Examining the quality of life in caregivers of patients with urologic cancer: A cross-sectional study in Crete, GreeceAnastasios Dimou, Maria Beltsiou, Antonios Christodoulakis, et al.
Cancer Research Communications|January 26, 2024
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing PanelsYiqing Zhao, Anastasios Dimou, Zachary C Fogarty, et al.
Advances in Therapy|June 25, 2024
Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLCKonstantinos Arnaoutakis, Yin Wan, Jennifer Elliott, et al.
Platelets|October 30, 2014
Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular eventsCarlos D Davila, Fernando Vargas, Kuan-Hsiang Gary Huang, et al.
The American Journal of Pathology|July 5, 2011
Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancerAnastasios Dimou, Seema Agarwal, Valsamo Anagnostou, et al.
Future Oncology (London, England)|April 19, 2021
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with <i>EGFR</i> exon 19 deletions or exon 21 mutationsKatherine B Winfree, Cliff Molife, Patrick M Peterson, et al.
Frontiers in Oncology|May 1, 2020
Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With <i>EGFR</i>-Mutant Non-small Cell Lung CancerTejas Patil, Jose M Pacheco, Anastasios Dimou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM databaseKaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
Sensors (Basel, Switzerland)|November 9, 2019
Deep Learning on Multi Sensor Data for Counter UAV Applications-A Systematic ReviewStamatios Samaras, Eleni Diamantidou, Dimitrios Ataloglou, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Thoracic Cancer|September 20, 2023
Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1 mediated by AXL overexpressionTara L Peters, Nan Chen, Logan C Tyler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2026
Examining the quality of life in caregivers of patients with urologic cancer: A cross-sectional study in Crete, GreeceAnastasios Dimou, Maria Beltsiou, Antonios Christodoulakis, et al.
Cancer Research Communications|January 26, 2024
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing PanelsYiqing Zhao, Anastasios Dimou, Zachary C Fogarty, et al.
Advances in Therapy|June 25, 2024
Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLCKonstantinos Arnaoutakis, Yin Wan, Jennifer Elliott, et al.
Platelets|October 30, 2014
Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular eventsCarlos D Davila, Fernando Vargas, Kuan-Hsiang Gary Huang, et al.
The American Journal of Pathology|July 5, 2011
Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancerAnastasios Dimou, Seema Agarwal, Valsamo Anagnostou, et al.
Future Oncology (London, England)|April 19, 2021
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with <i>EGFR</i> exon 19 deletions or exon 21 mutationsKatherine B Winfree, Cliff Molife, Patrick M Peterson, et al.
Frontiers in Oncology|May 1, 2020
Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With <i>EGFR</i>-Mutant Non-small Cell Lung CancerTejas Patil, Jose M Pacheco, Anastasios Dimou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2024
Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM databaseKaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, et al.
Sensors (Basel, Switzerland)|November 9, 2019
Deep Learning on Multi Sensor Data for Counter UAV Applications-A Systematic ReviewStamatios Samaras, Eleni Diamantidou, Dimitrios Ataloglou, et al.
Pageof 7